Pontifax Venture Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
LB Pharmaceuticalslbpharma.usNASDAQ: LBRXJan 2024
A clinical-stage biopharmaceutical company developing small molecule therapies for schizophrenia, bipolar depression, and other neuropsychiatric disorders.
BiotechHealthtechNew York, US
Zachary Prensky(Executive Officer, Director)Lauren Stipp(Executive Officer)Mark Panoff(Executive Officer)
BoardEdmund Sullivan(Director)Vincent Grattan(Director)
Board seatRan Nussbaum· per SEC Form D
Co-investorsTarnagulla VenturesVida VenturesTCG Crossover
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.